Lynch syndrome (LS) originally described by Warthin1 is a frequent cancer predisposition condition resulting from germline pathogenic variants in MLH1, MSH2, MSH6, PMS2 and EPCAM genes affecting DNA mismatch repair. Here, MSH2 is linked to cancer.